Elben Klinken Stade Buxtehude

Buxtehude, Lower Saxony 21614

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Melanoma, Metastatic or Unresectable Cutaneous Melanoma

Studies at this site

• Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma — Completed
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed